Copeland Capital Management LLC trimmed its holdings in Concentrix Corporation (NASDAQ:CNXC – Free Report) by 4.8% in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 1,210,480 shares of the company’s stock after selling 60,645 shares during the quarter. Copeland Capital Management LLC owned about 1.94% of Concentrix worth $55,864,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Envestnet Asset Management Inc. increased its position in shares of Concentrix by 32.9% during the 2nd quarter. Envestnet Asset Management Inc. now owns 220,030 shares of the company’s stock valued at $11,630,000 after purchasing an additional 54,449 shares during the last quarter. Brandywine Global Investment Management LLC purchased a new position in shares of Concentrix in the second quarter worth approximately $5,942,000. Natixis bought a new stake in Concentrix during the second quarter valued at approximately $1,872,000. Arrowstreet Capital Limited Partnership increased its holdings in Concentrix by 247.2% during the second quarter. Arrowstreet Capital Limited Partnership now owns 535,843 shares of the company’s stock valued at $28,322,000 after buying an additional 381,497 shares during the last quarter. Finally, Focus Partners Advisor Solutions LLC increased its holdings in Concentrix by 50.1% during the second quarter. Focus Partners Advisor Solutions LLC now owns 17,981 shares of the company’s stock valued at $950,000 after buying an additional 5,998 shares during the last quarter. Institutional investors own 90.34% of the company’s stock.
Concentrix Price Performance
Shares of Concentrix stock opened at $42.34 on Tuesday. The company has a market capitalization of $2.64 billion, a price-to-earnings ratio of 8.95, a PEG ratio of 0.56 and a beta of 0.50. The company has a quick ratio of 1.56, a current ratio of 1.56 and a debt-to-equity ratio of 1.10. The stock’s 50-day simple moving average is $38.82 and its 200-day simple moving average is $47.59. Concentrix Corporation has a 52 week low of $31.63 and a 52 week high of $66.00.
Analyst Ratings Changes
Check Out Our Latest Analysis on CNXC
Insider Buying and Selling
In other Concentrix news, CEO Christopher A. Caldwell purchased 2,000 shares of the company’s stock in a transaction on Thursday, October 30th. The stock was acquired at an average cost of $42.03 per share, for a total transaction of $84,060.00. Following the purchase, the chief executive officer directly owned 286,661 shares of the company’s stock, valued at $12,048,361.83. This trade represents a 0.70% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Over the last 90 days, insiders purchased 4,000 shares of company stock valued at $169,410. 3.20% of the stock is currently owned by insiders.
Concentrix Profile
Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.
Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.
Featured Articles
- Five stocks we like better than Concentrix
- Do not delete, read immediately
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Your “birthright claim” just got activated
- Wall Street Stockpicker Names #1 Stock of 2026
- Turn your “dead money” into $306+ monthly (starting this month)
Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.
